ID   KCC2G_RAT               Reviewed;         527 AA.
AC   P11730; Q64003; Q64004;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   24-JUL-2024, entry version 191.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type II subunit gamma;
DE            Short=CaM kinase II subunit gamma;
DE            Short=CaMK-II subunit gamma;
DE            EC=2.7.11.17;
GN   Name=Camk2g;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   TISSUE=Brain;
RX   PubMed=2846534; DOI=10.1016/s0021-9258(18)37561-6;
RA   Tobimatsu T., Kameshita I., Fujisawa H.;
RT   "Molecular cloning of the cDNA encoding the third polypeptide (gamma) of
RT   brain calmodulin-dependent protein kinase II.";
RL   J. Biol. Chem. 263:16082-16086(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS B AND C).
RC   TISSUE=Aortic smooth muscle;
RX   PubMed=8172610; DOI=10.1042/bj2990489;
RA   Zhou Z.L., Ikebe M.;
RT   "New isoforms of Ca2+/calmodulin-dependent protein kinase II in smooth
RT   muscle.";
RL   Biochem. J. 299:489-495(1994).
RN   [3]
RP   INDUCTION BY COCAINE.
RX   PubMed=16891908; DOI=10.1097/01.fjc.0000211796.45281.46;
RA   Henning R.J., Cuevas J.;
RT   "Cocaine activates calcium/calmodulin kinase II and causes cardiomyocyte
RT   hypertrophy.";
RL   J. Cardiovasc. Pharmacol. 48:802-813(2006).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311; SER-321; SER-325;
RP   SER-329; SER-355 AND SER-453, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that functions
CC       autonomously after Ca(2+)/calmodulin-binding and autophosphorylation,
CC       and is involved in sarcoplasmic reticulum Ca(2+) transport in skeletal
CC       muscle and may function in dendritic spine and synapse formation and
CC       neuronal plasticity (By similarity). In slow-twitch muscles, is
CC       involved in regulation of sarcoplasmic reticulum (SR) Ca(2+) transport
CC       and in fast-twitch muscle participates in the control of Ca(2+) release
CC       from the SR through phosphorylation of the ryanodine receptor-coupling
CC       factor triadin (By similarity). In the central nervous system, it is
CC       involved in the regulation of neurite formation and arborization. It
CC       may participate in the promotion of dendritic spine and synapse
CC       formation and maintenance of synaptic plasticity which enables long-
CC       term potentiation (LTP) and hippocampus-dependent learning. In response
CC       to interferon-gamma (IFN-gamma) stimulation, catalyzes phosphorylation
CC       of STAT1, stimulating the JAK-STAT signaling pathway (By similarity).
CC       {ECO:0000250|UniProtKB:Q13555, ECO:0000250|UniProtKB:Q923T9}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.17;
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin results in conformational change that relieves intrasteric
CC       autoinhibition and allows autophosphorylation of Thr-287 which turns
CC       the kinase in a constitutively active form and confers to the kinase a
CC       Ca(2+)-independent activity. {ECO:0000250|UniProtKB:Q13555}.
CC   -!- SUBUNIT: CAMK2 is composed of 4 different chains: alpha (CAMK2A), beta
CC       (CAMK2B), gamma (CAMK2G), and delta (CAMK2D). The different isoforms
CC       assemble into homo- or heteromultimeric holoenzymes composed of 12
CC       subunits with two hexameric rings stacked one on top of the other (By
CC       similarity). {ECO:0000250|UniProtKB:Q13555}.
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane {ECO:0000305};
CC       Peripheral membrane protein {ECO:0000305}; Cytoplasmic side
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=A;
CC         IsoId=P11730-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=P11730-2; Sequence=VSP_004781, VSP_004782;
CC       Name=C;
CC         IsoId=P11730-3; Sequence=VSP_004781, VSP_004783;
CC   -!- INDUCTION: By cocaine in cardiomyocytes. {ECO:0000269|PubMed:16891908}.
CC   -!- DOMAIN: The CAMK2 protein kinases contain a unique C-terminal subunit
CC       association domain responsible for oligomerization.
CC   -!- PTM: Autophosphorylation of Thr-287 following activation by
CC       Ca(2+)/calmodulin. Phosphorylation of Thr-287 locks the kinase into an
CC       activated state (By similarity). {ECO:0000250|UniProtKB:Q13555}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04063; AAA41857.1; -; mRNA.
DR   EMBL; S71570; AAB30670.1; -; mRNA.
DR   EMBL; S71571; AAB30671.1; -; mRNA.
DR   PIR; A31908; A31908.
DR   PIR; S43845; S43845.
DR   RefSeq; NP_598289.1; NM_133605.1. [P11730-1]
DR   RefSeq; XP_008768721.1; XM_008770499.2. [P11730-3]
DR   AlphaFoldDB; P11730; -.
DR   SMR; P11730; -.
DR   BioGRID; 251145; 10.
DR   IntAct; P11730; 3.
DR   MINT; P11730; -.
DR   BindingDB; P11730; -.
DR   ChEMBL; CHEMBL5109; -.
DR   iPTMnet; P11730; -.
DR   PhosphoSitePlus; P11730; -.
DR   jPOST; P11730; -.
DR   PaxDb; 10116-ENSRNOP00000062321; -.
DR   Ensembl; ENSRNOT00000066163.5; ENSRNOP00000062321.3; ENSRNOG00000009783.9. [P11730-1]
DR   Ensembl; ENSRNOT00055032943; ENSRNOP00055026678; ENSRNOG00055019165. [P11730-1]
DR   Ensembl; ENSRNOT00060021224; ENSRNOP00060016734; ENSRNOG00060012439. [P11730-1]
DR   Ensembl; ENSRNOT00065016670; ENSRNOP00065012713; ENSRNOG00065010269. [P11730-1]
DR   GeneID; 171140; -.
DR   KEGG; rno:171140; -.
DR   UCSC; RGD:621802; rat. [P11730-1]
DR   AGR; RGD:621802; -.
DR   CTD; 818; -.
DR   RGD; 621802; Camk2g.
DR   eggNOG; KOG0033; Eukaryota.
DR   GeneTree; ENSGT00940000156481; -.
DR   HOGENOM; CLU_000288_71_3_1; -.
DR   InParanoid; P11730; -.
DR   OrthoDB; 1121238at2759; -.
DR   PhylomeDB; P11730; -.
DR   BRENDA; 2.7.11.17; 5301.
DR   Reactome; R-RNO-3371571; HSF1-dependent transactivation.
DR   Reactome; R-RNO-399719; Trafficking of AMPA receptors.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-5673000; RAF activation.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-877300; Interferon gamma signaling.
DR   Reactome; R-RNO-936837; Ion transport by P-type ATPases.
DR   PRO; PR:P11730; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   Bgee; ENSRNOG00000009783; Expressed in frontal cortex and 19 other cell types or tissues.
DR   ExpressionAtlas; P11730; baseline and differential.
DR   GO; GO:0005954; C:calcium- and calmodulin-dependent protein kinase complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; TAS:RGD.
DR   GO; GO:0010975; P:regulation of neuron projection development; ISO:RGD.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; IDA:SynGO.
DR   GO; GO:1903076; P:regulation of protein localization to plasma membrane; IGI:ARUK-UCL.
DR   GO; GO:1901897; P:regulation of relaxation of cardiac muscle; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IDA:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IDA:RGD.
DR   CDD; cd14086; STKc_CaMKII; 1.
DR   Gene3D; 3.10.450.50; -; 1.
DR   Gene3D; 6.10.140.620; -; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR013543; Ca/CaM-dep_prot_kinase-assoc.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR032710; NTF2-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347:SF441; CALCIUM_CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II SUBUNIT GAMMA; 1.
DR   PANTHER; PTHR24347; SERINE/THREONINE-PROTEIN KINASE; 1.
DR   Pfam; PF08332; CaMKII_AD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54427; NTF2-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calmodulin-binding;
KW   Developmental protein; Differentiation; Kinase; Membrane; Neurogenesis;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Sarcoplasmic reticulum; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..527
FT                   /note="Calcium/calmodulin-dependent protein kinase type II
FT                   subunit gamma"
FT                   /id="PRO_0000086103"
FT   DOMAIN          14..272
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          283..292
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q13555"
FT   REGION          294..316
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q13555"
FT   REGION          344..389
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        359..383
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        136
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         20..28
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         43
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         287
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q13555"
FT   MOD_RES         306
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         307
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         311
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         321
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         325
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         355
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         453
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         316..336
FT                   /note="Missing (in isoform B and isoform C)"
FT                   /evidence="ECO:0000303|PubMed:8172610"
FT                   /id="VSP_004781"
FT   VAR_SEQ         351..361
FT                   /note="KKRKSSSSVHL -> PEQQQKQSRKPSPRARDPLQTA (in isoform
FT                   B)"
FT                   /evidence="ECO:0000303|PubMed:8172610"
FT                   /id="VSP_004782"
FT   VAR_SEQ         352..362
FT                   /note="Missing (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:8172610"
FT                   /id="VSP_004783"
FT   CONFLICT        2
FT                   /note="A -> E (in Ref. 2; AAB30670/AAB30671)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   527 AA;  59038 MW;  58DBF1B72F64FA31 CRC64;
     MATTATCTRF TDDYQLFEEL GKGAFSVVRR CVKKTSTQEY AAKIINTKKL SARDHQKLER
     EARICRLLKH PNIVRLHDSI SEEGFHYLVF DLVTGGELFE DIVAREYYSE ADASHCIHQI
     LESVNHIHQH DIVHRDLKPE NLLLASKCKG AAVKLADFGL AIEVQGEQQA WFGFAGTPGY
     LSPEVLRKDP YGKPVDIWAC GVILYILLVG YPPFWDEDQH KLYQQIKAGA YDFPSPEWDT
     VTPEAKNLIN QMLTINPAKR ITADQALKHP WVCQRSTVAS MMHRQETVEC LRKFNARRKL
     KGAILTTMLV SRNFSVGRQS SAPASPAASA AGLAGQAAKS LLNKKSDGGV KKRKSSSSVH
     LMEPQTTVVH NATDGIKGST ESCNTTTEDE DLKVRKQEII KITEQLIEAI NNGDFEAYTK
     ICDPGLTSFE PEALGNLVEG MDFHKFYFEN LLSKNSKPIH TTILNPHVHV IGEDAACIAY
     IRLTQYIDGQ GRPRTSQSEE TRVWHRRDGK WLNVHYHCSG APAAPLQ
//
